Blue willow biologics stock symbol
WebBlueWillow Biologics operates as a clinical-stage privately-held biopharmaceutical company. It focuses on developing and commercializing topical antiseptic and anti-infective products and intranasal vaccines using its patented nanotechnology platform. Its platform employs novel oil-in-water nano-droplets for products administered to the skin ... WebMay 29, 2024 · ANN ARBOR, Mich., May 29, 2024 /PRNewswire/ -- BlueWillow Biologics ® today announced the issuance of U.S. patent number 10,138,279 covering an intranasal NanoVax ® anthrax vaccine.
Blue willow biologics stock symbol
Did you know?
WebHeader placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit. WebFunding. BlueWillow Biologics has raised a total of $86.3M in funding over 10 rounds. Their latest funding was raised on Sep 26, 2024 from a Grant round. BlueWillow Biologics is …
WebApr 5, 2024 · Company. Willow Biosciences Inc. is a Canada-based biotechnology company. The Company is developing and commercializing bio-based manufacturing processes and products for its business-to-business (B2B) partners and their customers. The Company is engaged in developing and producing plant derived ingredients for … WebJan 1, 2024 · www.bluewillow.com Formerly Known As NanoBio Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Pharmaceuticals Biotechnology Primary Office 2311 Green Road Ann …
WebFunding. BlueWillow Biologics has raised a total of $86.3M in funding over 10 rounds. Their latest funding was raised on Sep 26, 2024 from a Grant round. BlueWillow Biologics is funded by 9 investors. Small Business Innovation Research and Line Moon Ventures are the most recent investors.
WebAbout BlueWillow Biologics Stock. BlueWillow Biologics operates as a clinical-stage privately-held biopharmaceutical company. It focuses on developing and …
WebNov 3, 2024 · ANN ARBOR, Mich.–(BUSINESS WIRE)–BlueWillow Biologics, Inc. today announced that the company will present positive interim data from its phase 1 clinical trial of a novel intranasal anthrax vaccine at a Lightning Talks Session of BARDA’s Industry Day, November 3 and 4, 2024. BlueWillow’s rPA/NE01 anthrax vaccine, BW-1010, … brennan\\u0027s coffee athens ohioWebMar 2, 2024 · October 1, 2024. BlueWillow Biologics ®, a clinical-stage biopharmaceutical company, has been awarded a Fast Track Small Business Research Innovation contract … counter security doorWebJul 19, 2024 · Starting us off today is Twist Biosciences. In brief, Twist is a leading name in the synthetic biology industry today. The company’s core work revolves around its proprietary DNA synthesis ... counter security gatesWebMar 2, 2024 · BlueWillow Biologics is developing a new generation of safe and effective nasal vaccines to help protect humankind from respiratory infections, sexually transmitted diseases and food allergies. brennan\u0027s downtownWebMar 15, 2024 · 2 equities research analysts have issued 1-year price objectives for HCW Biologics' stock. Their HCWB share price forecasts range from $4.00 to $8.00. On average, they anticipate the company's share price to reach $6.00 in the next twelve months. This suggests a possible upside of 344.4% from the stock's current price. brennan\u0027s credit card nameWebApr 2, 2024 · BlueWillow Biologics ® is a clinical-stage, privately-held biopharmaceutical company focused on developing and commercializing topical antiseptic and anti-infective products and intranasal ... counter security grilleWebBlueWillow Biologics is a biopharmaceutical company developing and commercializing topical antiseptic, anti-infective products, and intranasal vaccines. It uses a nanotechnology platform that employs oil-in-water nano-droplets for products administered to the skin and nose. BlueWillow’s offers NanoBio Protect product, and alcohol- and ... counter security hounslow